Merimsky O, Laufer R, Chaitchik S
Department of Oncology, Tel-Aviv Medical Center, Israel.
J Urol (Paris). 1989;95(4):243-5.
Renal Cell Carcinoma (RCC) in a single kidney is a rare occurrence, more so when it concerns agenesis of the kidney. Chemotherapy of metastatic renal cell carcinoma has a poor effect. We report a case of a man, 49 years of age, with agenesis of one kidney, admitted with a metastatic RCC of his only kidney. Survival of 15 months duration was achieved by therapy combining Provera, Vinblastine and Alpha-C-Recombinant Interferon.
孤立肾肾细胞癌(RCC)较为罕见,当涉及肾缺如时则更为罕见。转移性肾细胞癌的化疗效果不佳。我们报告一例49岁男性患者,其一侧肾脏缺如,因唯一肾脏发生转移性肾细胞癌入院。通过联合使用安宫黄体酮、长春碱和α - C重组干扰素进行治疗,患者存活了15个月。